Tradeoffs

Health care has long lagged behind other industries when it comes to cybersecurity. But with ransomware attacks against the industry on the rise, providers are quickly trying to close the gap and protect their systems and patients.Guests:Karen Sprenger, CISSP, GCFE, Chief Operating Officer and Chief Ransomware Negotiator, LMG SecurityM. Eric Johnson, PhD, Ralph Owen Dean and Bruce D. Henderson Professor of Strategy, Vanderbilt University Owen Graduate School of ManagementAnahi Santiago, Chief Information Security Officer, ChristianaCareSaad Chaudhry, MPP, Chief Information Officer, Luminis HealthRead a full transcript, dig into the numbers, and learn more about ransomware negotiator Karen Sprenger on our website: https://tradeoffs.org/2021/07/29/health-cares-ransomware-wake-up-callSign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletterSupport this type of journalism today, with a gift: https://tradeoffs.org/donateFollow us on Twitter: https://twitter.com/tradeoffspod Hosted on Acast. See acast.com/privacy for more information.

As gun violence continues to soar in U.S. cities, one violence prevention specialist tries to stem the tide of homicides in his hometown.Guest: James "JT" Timpson, Director for Community Partnerships and Safety, Roca Maryland and Roca Impact InstituteRead a full transcript and dig deeper into the issues explored in today's episode: https://tradeoffs.org/2021/07/22/sacrifices-and-small-wins-the-fight-against-rising-gun-violence/Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletterSupport this type of journalism today, with a gift: https://tradeoffs.org/donateFollow us on Twitter: https://twitter.com/tradeoffspod Hosted on Acast. See acast.com/privacy for more information.

A young woman living with cerebral palsy shares the struggles, fears and silver linings she’s experienced during the pandemic.Guest: Jeiri Flores, disability rights advocateRead a full transcript and dig deeper into the issues explored in today's episode: https://tradeoffs.org/2021/07/15/one-womans-year-surviving-the-pandemic-with-a-disabilitySign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletterSupport this type of journalism today, with a gift: https://tradeoffs.org/donateFollow us on Twitter: https://twitter.com/tradeoffspod Hosted on Acast. See acast.com/privacy for more information.

A congressional ban on removing anyone from Medicaid is likely to expire early next year. What will happen to people who lose their coverage, and how are states preparing for this unprecedented undertaking?Guests:Sara Rosenbaum, JD, Harold and Jane Hirsh Professor of Health Law and Policy, Milken Institute School of Public Health, George Washington UniversityJami Snyder, Director, AHCCCS Dave Richard, Deputy Secretary, North Carolina MedicaidRead a full transcript and see which states are working ahead to prepare for the end of the public health emergency and state-by-state estimates of how many people could lose coverage on our website: Dig deeper into the issues explored in today's episode: https://tradeoffs.org/2021/07/08/why-millions-could-lose-medicaid-next-year/Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletterSupport this type of journalism today, with a gift: https://tradeoffs.org/donateFollow us on Twitter: https://twitter.com/tradeoffspod Hosted on Acast. See acast.com/privacy for more information.

Many cities across the United States are rethinking the role of police in responding to mental health emergencies. Miami-Dade County has spent the last two decades revamping their policing — along with many other aspects of how their criminal justice system treats people in crisis. What lessons have they learned?Guests:Steve Leifman, JD, Associate Administrative Judge, Eleventh Judicial Circuit Court of Florida; Founder, Miami-Dade County Criminal Mental Health ProjectCarol Caraballo, MSW, MPA, LCSW, Vice President of Behavioral Health Services, Thriving Mind South FloridaDig deeper into the issues explored in today's episode: https://tradeoffs.org/2021/07/01/one-countys-20-year-effort-to-decriminalize-mental-illnessSign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletterSupport this type of journalism today, with a gift: https://tradeoffs.org/donateFollow us on Twitter: https://twitter.com/tradeoffspod Hosted on Acast. See acast.com/privacy for more information.

How is the pharmaceutical industry reacting to the FDA’s surprising approval of a controversial Alzheimer’s drug, and what do they make of its $56,000 price tag?This is the last episode in our weeklong series examining the potentially sweeping consequences this drug, known as aducanumab, could have on millions of patients’ lives and billions of dollars in health care spending.Guest:Luke Timmerman, Journalist/Founder, Timmerman ReportExplore the full series and additional resources: https://tradeoffs.org/aducanumabRead a transcript of this episode: https://tradeoffs.org/2021/06/25/the-aducanumab-aftermath-the-industry/Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletterSupport this type of journalism today, with a gift: https://tradeoffs.org/donateFollow us on Twitter: https://twitter.com/tradeoffspod Hosted on Acast. See acast.com/privacy for more information.

A controversial new $56,000 Alzheimer’s drug could wreak financial havoc on insurers, seniors and taxpayers.This episode is part of a special weeklong series examining the potentially sweeping consequences this drug, known as aducanumab, could have on millions of patients’ lives and billions of dollars in health care spending.Guest:Mark Miller, PhD, Executive Vice President for Health Care, Arnold VenturesExplore the full series and additional resources: https://tradeoffs.org/aducanumabRead a transcript of this episode: https://tradeoffs.org/2021/06/24/the-aducanumab-aftermath-the-payer/Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletterSupport this type of journalism today, with a gift: https://tradeoffs.org/donateFollow us on Twitter: https://twitter.com/tradeoffspod Hosted on Acast. See acast.com/privacy for more information.

Desperate to slow her cognitive decline, one patient shares her hopes and concerns about the first new Alzheimer’s drug in nearly 20 years.This episode is part of a special weeklong series examining the potentially sweeping consequences this drug, known as aducanumab, could have on millions of patients’ lives and billions of dollars in health care spending.Guest: Arthena Caston, Alzheimer’s patient and advocateExplore the full series and additional resources: https://tradeoffs.org/aducanumabRead a transcript of this episode: https://tradeoffs.org/2021/06/23/the-aducanumab-aftermath-the-patient/Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletterSupport this type of journalism today, with a gift: https://tradeoffs.org/donateFollow us on Twitter: https://twitter.com/tradeoffspod Hosted on Acast. See acast.com/privacy for more information.

A costly, controversial new Alzheimer’s drug is sending shockwaves through the U.S. health care system. How are doctors grappling with questions about its safety and efficacy? This is the first episode in a special conversation series featuring different people reckoning with the potentially sweeping consequences this drug could have on millions of patients’ lives and billions of dollars in health care spending.Guest: Winston Chiong, MD, PhD, Associate Professor of Neurology, University of California, San FranciscoExplore the full series and additional resources: https://tradeoffs.org/aducanumabRead a transcript of this episode: https://tradeoffs.org/2021/06/22/aducanumab-doctor-transcript/Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletterSupport this type of journalism today, with a gift: https://tradeoffs.org/donateFollow us on Twitter: https://twitter.com/tradeoffspod Hosted on Acast. See acast.com/privacy for more information.

Health policy experts are kicking off the summer with back-to-back conferences: AcademyHealth's Annual Research Meeting and the 10th Annual Conference of the American Society of Health Economists (ASHEcon). Hop on the Tradeoffs Tours bus for conference tips, stories and exciting research with a conference veteran, Kosali Simon.Guest: Kosali Simon, PhD, Herman B. Wells Endowed Professor, Associate Vice Provost for Health Sciences; Indiana UniversityFind links to the conferences' full agendas and an episode transcript on our website: https://tradeoffs.org/2021/06/17/babies-boats-abstracts-an-insiders-guide-to-health-policy-conferences/Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletterSupport this type of journalism today, with a gift: https://tradeoffs.org/donateFollow us on Twitter: https://twitter.com/tradeoffspod Hosted on Acast. See acast.com/privacy for more information.